Tanruprubart is a humanized monoclonal antibody targeting C1q in the classical complement pathway, applicable for studying Guillain-Barre syndrome (GBS) by preventing persistent neuroinflammation and nerve damage in the early stages of GBS.
Molecular Weight:
145.5
Purity:
95.00%
CAS Number:
[2065212-40-8]
Target:
Complement System
* VAT and and shipping costs not included. Errors and price changes excepted